Header Logo

Connection

Oluwatomisin Atolagbe to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications Oluwatomisin Atolagbe has written about Cell Line, Tumor.
Oluwatomisin Atolagbe
Connection Strength
0.028
Cell Line, Tumor
  1. LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. J Exp Med. 2021 07 05; 218(7).
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.